Hershey Trust CO Eagle Pharmaceuticals, Inc. Transaction History

Hershey Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $93,623 - $119,257	-2,138 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$41.72 - $51.34 $41,720 - $51,340	-1,000 Reduced 31.87%	2,138 $100,000
Q2 2020 Jul 22, 2020	SELL	$43.24 - $55.02 $517,107 - $657,984	-11,959 Reduced 79.21%	3,138 $151,000
Q3 2017 Oct 24, 2017	BUY	$46.62 - $60.36 $703,822 - $911,254	15,097	15,097 $900,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.